Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Surgical Innovations Group's Enterprise Value is £4.28 Mil.
Surgical Innovations Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was £-0.88 Mil. Therefore, Surgical Innovations Group's EV-to-EBIT ratio for today is -4.88.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Surgical Innovations Group (LSE:SUN) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Surgical Innovations Group's EV-to-EBIT for today is
Surgical Innovations Group's current Enterprise Value is £4.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was £-0.88 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Surgical Innovations Group's EV-to-EBITDA for today is:
Surgical Innovations Group's current Enterprise Value is £4.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was £-0.22 Mil.
Surgical Innovations Group's current Enterprise Value is £4.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was £11.60 Mil.
Surgical Innovations Group's current Enterprise Value is £4.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was £0.57 Mil.
Surgical Innovations Group's current Enterprise Value is £4.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was £0.34 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Innovations Group Enterprise Value Related Terms
Surgical Innovations Group Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:SUN vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Surgical Innovations Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Innovations Group Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Surgical Innovations Group's Enterprise Value falls into.
Surgical Innovations Group Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Surgical Innovations Group's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Innovations Group (LSE:SUN) has a Enterprise Value of £4.28 Mil as of Jul. 02, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Surgical Innovations Group and its competitors.
Is Surgical Innovations Group's Enterprise Value too high?
Surgical Innovations Group's current Enterprise Value is £4.28 Mil.
How does Surgical Innovations Group's Enterprise Value compare to ABT and SYK?
Surgical Innovations Group's Enterprise Value of £4.28 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Surgical Innovations Group and its competitors. Surgical Innovations Group's current Enterprise Value is £4.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Based on GuruFocus' analysis, Surgical Innovations Group (LSE:SUN) is currently considered Possible Value Trap. The stock's GF Value™ is £0.01, compared to a current price of £0.00 — trading 52.5% below its estimated fair value. The current Enterprise Value is £4.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current Enterprise Value is £4.28 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SUN has been successfully added to your 